Medifron DBT Co., Ltd. announced a private placement of series 11 unregistered coupon non-guaranteed private convertible bond for gross proceeds of KRW 5,000,000,000 on June 22, 2022. The transaction will include participation from new investors Shinhan Financial Investment Co., Ltd. for KRW 1,500,000,000, Mirae Asset Securities Co. Ltd. for KRW 2,000,000,000,Pita KOSDAQ Venture General Private Equity Trust No.2, EIP ESG KOSDAQ Venture Specialized Investors General Private Equity Trust No.

1, funds managed by NH Investment & Securities Co., Ltd. for KRW 1,000,000,000, KY KOSDAQ Venture Specialized Investment Criminal Equity Trust No. 3 , fund managed by KB Securities Co., Ltd for KRW 500,000,000. The bonds carry 0% coupon rate, 0% yield to maturity, and will mature on June 30, 2027.

The bonds are 100% convertible into 2,797,985 common shares of the company representing 6.42% stake, at a fixed conversion price of KRW 1,787 per share from June 30, 2023 till May 30, 2027. The subscription and payment date for the bonds is June 30, 2022. The transaction has been approved by the board of directors of the company.

The bonds will be subject to a hold period of one year.